Healthcare private equity firms have been at the center of controversy in recent months after a year of notable Chapter 11 filings and increased regulatory scrutiny from a number of states.
Healthcare private equity firms have been at the center of controversy in recent months after a year of notable Chapter 11 filings and increased regulatory scrutiny from a number of states.